Trademark: 85694993
Word
CHAMPIONS TUMORGRAFT
Status
Dead
Status Code
710
Status Date
Friday, August 28, 2020
Serial Number
85694993
Registration Number
4471792
Registration Date
Tuesday, January 21, 2014
Mark Type
4000
Filing Date
Friday, August 3, 2012
Published for Opposition
Tuesday, March 5, 2013
Cancellation Date
Friday, August 28, 2020

Trademark Owner History
Champions Biotechnology, Inc. - Original Registrant

Classifications
42 Medical research and development in the field of treatment for cancer and oncology, and treatment of inflammation and autoimmune diseases; Scientific research services for medical purposes; scientific research services for diagnosis and analysis of cancer; medical and scientific research in the fields of treatment for cancer and oncology, and treatment of inflammation and autoimmune diseases; Medical research in the field of molecular signatures of tissues, namely, dna, rna, or proteins within a tumor, prediction of cancer risk, diagnosis, prognosis, response to therapy, and identification of new molecular targets for the development of more effective cancer prevention and personalized treatment programs; Analysis of the mode of action of chemical combinations on animals; biomedical research services; medical and scientific research in the field of cancer treatment and diagnosis; medical and scientific research in the field of medical imaging; medical and scientific research in the field of cancer diseases; medical and scientific research, namely, conducting clinical trials; medical research; medical research services in the field of cancer; pharmaceutical research and development; pharmaceutical research services; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; providing medical testing services and information in the field of cancer research and disease classification; providing reagent sample testing and diagnostic services for others in the fields of science and research related thereto; research and development and consultation related thereto in the field of treatment and prevention of cancer diseases; research and development in the field of cancer diseases; research and development in the pharmaceutical and biotechnology fields; research and development of pharmaceuticals for the treatment of age-related diseases and cancer; research in the field of cancer diseases; research on the subject of pharmaceuticals; scientific and technological services, namely, animal testing and modeling in the field of cancer diseases; scientific research; scientific research and development; scientific research consulting in the field of cancer diseases; scientific research for medical purposes in the area of cancerous diseases; scientific study and research in the fields of animal testing and modeling of medical devices and therapeutic agents; testing, inspection or research of pharmaceuticals, cosmetics or foodstuff
44 Providing a database in the field of human clinical and molecular data accumulation and analysis for aiding medical diagnostics, prognostics and the evaluation and testing of drug and treatment effectiveness, namely, providing data regarding tumor-specific molecular signatures, providing objective data on the effectiveness of a drug and diagnostic test and providing evidence-based treatment protocols by effectively comparing standard treatment therapies with clinical outcomes; providing an internet-accessible medical records portal for use by physicians, patients and researchers for the storage and accessibility of electronic data in the field of human clinical and molecular data accumulation and analysis for aiding medical diagnostics, prognostics and the evaluation and testing of drug and treatment effectiveness; Medical diagnostic services for cancer treatment purposes in the field of molecular oncology, namely, medical diagnostic testing consisting of tumor testing, tumor profiling, molecular diagnostics, molecular tumor diagnostics, evaluation and testing of drug and treatment effectiveness, chemotherapy response and genomic pathway activation signaling; Medical diagnostic testing services in the fields of oncology and solid tumor pathology; Medical diagnostic services relating to the detection of cancer; medical diagnostic screening and analytical services in the field of medical diagnostic testing through isolation and extraction of cells for analysis and medical diagnostic screening and analytical services used in the oncology field; Medical and veterinary services in the fields of analysis and diagnosis of metastasizing cancer species with liquid samples and tissue samples of the patient
Color is not claimed as a feature of the mark.
"TUMORGRAFT"
CHAMPIONS TUMOR GRAFT

Trademark Events
Aug 28, 2020
Cancelled Sec. 8 (6-Yr)
May 29, 2019
Withdrawal Of Attorney Granted
May 29, 2019
Teas Withdrawal Of Attorney Received
Jan 21, 2019
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Jan 21, 2014
Registered-Principal Register
Dec 19, 2013
Notice Of Acceptance Of Statement Of Use E-Mailed
Dec 18, 2013
Law Office Registration Review Completed
Dec 12, 2013
Allowed Principal Register - Sou Accepted
Nov 20, 2013
Statement Of Use Processing Complete
Oct 11, 2013
Use Amendment Filed
Nov 12, 2013
Case Assigned To Intent To Use Paralegal
Oct 11, 2013
Teas Statement Of Use Received
Apr 30, 2013
Noa E-Mailed - Sou Required From Applicant
Mar 5, 2013
Official Gazette Publication Confirmation E-Mailed
Mar 5, 2013
Published For Opposition
Feb 13, 2013
Notification Of Notice Of Publication E-Mailed
Jan 30, 2013
Law Office Publication Review Completed
Jan 22, 2013
Approved For Pub - Principal Register
Jan 17, 2013
Examiner's Amendment Entered
Jan 16, 2013
Assigned To Lie
Jan 16, 2013
Notification Of Examiners Amendment E-Mailed
Jan 16, 2013
Examiners Amendment E-Mailed
Jan 16, 2013
Examiners Amendment -Written
Jan 7, 2013
Notification Of Non-Final Action E-Mailed
Jan 7, 2013
Non-Final Action E-Mailed
Jan 7, 2013
Non-Final Action Written
Dec 17, 2012
Assigned To Examiner
Dec 1, 2012
Assigned To Examiner
Aug 14, 2012
Notice Of Pseudo Mark Mailed
Aug 13, 2012
New Application Office Supplied Data Entered In Tram
Aug 7, 2012
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24